IP Library Granted Patent US 9,566,274
Granted Patent B2
US 9,566,274 · App. 14/559,619 · Granted Feb 14, 2017

Methods for enhancing the release and absorption of water insoluble active agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,566,274
App. No.
14/559,619
Granted
Feb 14, 2017
Kind
B2
Abstract

Methods for enhancing the release and/or absorption of poorly water soluble active agents are described herein. The method involves dissolving, melting, or suspending a poorly water soluble active agent in one or more molten fatty acids, conjugated fatty acids, (semi-) solid surfactants of high HLB value, and/or hydrophilic polymers. The molten active agent mixture is then suspended and homogenized in a hydrophilic or lipophilic carrier to form microparticles suspended in the hydrophilic or lipophilic carrier. The particles suspended in the hydrophilic or lipophilic carrier can be encapsulated in a hard or soft gelatin or non-gelatin capsule. It is believed that the microparticles produced by the method described above will exhibit enhanced dissolution profiles. In vitro release studies of formulations containing cilostazol and fenofibrate showed 100% dissolution of cilostazol in 15 minutes and over 90% dissolution of fenofibrate in 35 minutes.

Claims (23)

1. A method of making microparticles comprising:

(a) dissolving, melting, or suspending fenofibrate or cilostazol in at least one fatty acid or conjugated fatty acid, surfactant, hydrophilic polymer, or combinations thereof to form a mixture, and

(b) mixing the mixture of step (a) with a liquid hydrophilic or lipophilic carrier to form microparticles having a diameter from 100 nm to 25 microns.

2. The method of claim 1 , wherein the surfactant in step (a) has an HLB greater than about 10.

3. The method of claim 2 , wherein the surfactant in step (a) has an HLB greater than about 16.

4. The method of claim 1 , wherein the concentration of the surfactant is from about 1% to about 50% by weight of the composition.

5. The method of claim 4 , wherein the concentration of the surfactant is from about 5% to about 15% by weight of the composition.

6. The method of claim 1 , wherein the conjugated fatty acid is selected from the group consisting of C 10 -C 18 8 monoglycerides, C 10 -C 18 fatty acids conjugated to a polyalkylene oxide, C 10 -C 1 8 fatty acids conjugated to a monosaccharide, and combinations thereof.

7. The method of claim 1 , wherein the concentration of the conjugated fatty acid is from about 1% to about 20% by weight of the composition.

8. The method of claim 1 , wherein the concentration of the conjugated fatty acid is from about 5% to about 15% by weight of the composition.

9. The method of claim 1 , wherein the fatty acid is a C 10 -C 18 fatty acid.

10. The method of claim 1 , wherein the fatty acid is selected from the group consisting of dodecanoic (lauric) acid, tetradecanoic (myristic) acid, hexadecanoic (palmitic) acid, heptadecanoic (margaric) acid, octadecanoic (stearic) acid, eicosanoic (arachidic) acid, docosanoic (behenic) acid, tetracosanoic (lignoceric) acid, hexacosanoic (cerotic) acid, heptacosanoic (carboceric) acid, octacosanoic (montanic) acid, triacontanoic (melissic) acid, dotriacontanoic (lacceroic) acid, tritriacontanoic (ceromelissic) acid, tetratriacontanoic (geddic) acid, pentatriacontanoic (ceroplastic) acid, and combinations thereof.

11. The method of claim 1 , wherein the concentration of the fatty acid is from about 1% to about 20% by weight of the composition.

12. The method of claim 1 , wherein the concentration of the fatty acid is from about 5% to about 15% by weight of the composition.

13. The method of claim 1 , wherein the hydrophilic polymer is selected from the group consisting of poloxomers, poloxamines, and polyethylene glycols.

14. The method of claim 1 , wherein the concentration of the hydrophilic polymer is from about 1% to about 80% by weight of the composition.

15. The method of claim 14 , wherein the concentration of the hydrophilic polymer is from about 30% to about 60% by weight of the composition.

16. The method of claim 14 , wherein the concentration of the hydrophilic polymer is from about 5% to about 15% by weight of the composition.

17. The method of claim 1 , wherein the water-insoluble active agent is melted, dissolved or dispersed in the coating material at a temperature between about 40° C. and about 70° C.

18. The method of claim 1 , wherein the mixture of step (a) is added to the hydrophilic or lipophilic carrier at room temperature or lower.

19. The method of claim 1 , wherein the mixture of step (a) is suspended and homogenized in a hydrophilic or lipophilic carrier to form the microparticles.

20. The method of claim 19 , wherein the mixture of step (a) and the hydrophilic or lipophilic carrier is homogenized for less than about 30 minutes.

21. The method of claim 1 , wherein the hydrophilic carrier comprises polyethylene glycol, water, and one or more surfactants.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2014
From: FATMI, AQEEL
To: BANNER PHARMACAPS, INC.
Reel/Frame 034416/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2014
From: BANNER PHARMACAPS INC.
To: BANNER LIFE SCIENCES LLC
Reel/Frame 034416/0595 →